Norah Terrault, MD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Norah Terrault, MD, MPH

Assistant Professor, Department of Medicine (Gastroenterology), UCSF

Phone: (415) 353-2318 (appts)
Box 0538, UCSF
San Francisco, CA 94143-0538

View on UCSF Profiles


Additional Websites


Education

University of Alberta, MD, 1984-87
University of Toronto, FRCPC, 1988-92, Internal Medicine
University of Toronto, FRCPC, 1992-94, Gastroenterology
University of California, Berkeley, MPH, 1996-97, Epidemiology

Professional Experience

  • 1987-88 Comprehensive internship, University of Toronto
  • 1988-91
    Residency in Internal Medicine, University of Toronto
  • 1991-93
    Residency in Gastroenterology, University of Toronto
  • 1993-94
    Clinical Fellowship, University of Toronto
  • 1994-97
    Research Fellowship, University of California San Francisco
  • 1997-2002
    Adjunct Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco
  • 2002-present
    Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco

Honors & Awards

  • 1991
    Dr. D.H. Cowan, University of Toronto Teaching Award
  • 1992
    CAG Residents' Presentation Award
  • 1994
    CASL Presentation Award
  • 1994-96
    Canadian Liver Foundation Fellowship Award
  • 1996
    Canadian Liver Foundation Fellowship Award (declined)
  • 1996
    Medical Research Council of Canada Fellowship Award (declined)
  • 1996-8
    Dr. Saul Krugman Career Development Award
  • 1997-9
    Jan Albrecht Career Development Award

Selected Publications

  1. Campos-Varela I, Straley S, Agudelo EZ, Carlson L, Terrault NA. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients. Liver Transpl. 2015 Feb; 21(2):272-4.
    View on PubMed
  2. Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH. Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg? Hepatology. 2015 Feb; 61(2):703-11.
    View on PubMed
  3. Goel A, Terrault N. Reply. Liver Transpl. 2015 Mar; 21(3):416.
    View on PubMed
  4. Tejada-Strop A, Drobeniuc J, Mixson-Hayden T, Forbi JC, Le NT, Li L, Mei J, Terrault N, Kamili S. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots. J Virol Methods. 2015 Feb; 212:66-70.
    View on PubMed
  5. Kwo PY, Mantry PS, Coakley E, Te HS, Vargas HE, Brown R, Gordon F, Levitsky J, Terrault NA, Burton JR, Xie W, Setze C, Badri P, Pilot-Matias T, Vilchez RA, Forns X. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371(25):2375-82.
    View on PubMed
  6. Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology. 2015 Jan; 148(1):108-17.
    View on PubMed
  7. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8.
    View on PubMed
  8. Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1.
    View on PubMed
  9. Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, BarĂ³n AE, Inadomi J, Terrault N, Rosen HR. Survival Benefit of Repeat Liver Transplantation in the United States: A Serial MELD Analysis by Hepatitis C Status and Donor Risk Index. Am J Transplant. 2014 Nov; 14(11):2588-94.
    View on PubMed
  10. Campos-Varela I, Peters MG, Terrault NA. Advances in Therapy for HIV/Hepatitis C Virus-Coinfected Patients in the Liver Transplant Setting. Clin Infect Dis. 2015 Jan 1; 60(1):108-16.
    View on PubMed
  11. Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: The hepatitis C experience. Liver Transpl. 2014 Oct; 20(10):1202-10.
    View on PubMed
  12. Price JC, Terrault NA. CON Sofosbuvir and Ribavirin Use in Wait-Listed Patients with Hepatitis C Should be Selective. Liver Int. 2014 Sep 2.
    View on PubMed
  13. Terrault NA, Stock PG. Management of hepatitis C in kidney transplant patients: on the cusp of change. Am J Transplant. 2014 Sep; 14(9):1955-7.
    View on PubMed
  14. Flemming JA, Yang JD, Vittinghoff E, Kim WR, Terrault NA. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model. Cancer. 2014 Nov 15; 120(22):3485-93.
    View on PubMed
  15. Terrault NA, Hassanein T, Howell CD, Joshi S, Lake J, Sher L, Vargas H, McIntosh J, Tang S, Jenkins TM. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. J Hepatol. 2014 Dec; 61(6):1253-9.
    View on PubMed
  16. Ghany M, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Suk-Fong Lok A. Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and HBV Genotype. Clin Gastroenterol Hepatol. 2014 Jul 7.
    View on PubMed
  17. Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014 Aug; 14(8):1870-9.
    View on PubMed
  18. Saxena V, Monto A, Terrault N. Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals - authors' reply. Aliment Pharmacol Ther. 2014 Jun; 39(12):1428.
    View on PubMed
  19. Sarkar M, Terrault NA. Ending vertical transmission of hepatitis B: The third trimester intervention. Hepatology. 2014 Aug; 60(2):448-51.
    View on PubMed
  20. Burton JR, O'Leary JG, Verna EC, Saxena V, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA. A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy. J Hepatol. 2014 Sep; 61(3):508-14.
    View on PubMed

Go to UCSF Profiles, powered by CTSI